+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiac Pacemaker Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786930
The global cardiac pacemaker market size attained a value of about USD 4.76 billion in 2022. The market is further expected to grow at a CAGR of 3.13% to attain a value of USD 6.28 billion by 2031. The growth of the market can be attributed to the increasing prevalence of heart rhythm disorders, such as bradycardia and heart block.

Cardiac Pacemaker Market: Introduction

A cardiac pacemaker is a small, implantable device that helps regulate the heartbeat of individuals who have abnormal or irregular heart rhythms, also known as arrhythmias. The device is placed under the skin in the chest and connected to the heart through one or more wires (leads).

The pacemaker continuously monitors the heart's electrical activity and sends electrical impulses to the heart muscle to help it beat regularly and at a consistent rate. The device can be programmed to deliver different types of electrical impulses depending on the needs of the patient.

Cardiac pacemakers are typically used to treat bradycardia, a condition where the heart beats too slowly, and heart block, a condition where the electrical signals that control the heartbeat are blocked or delayed. The device can also be used to treat tachycardia, a condition where the heart beats too quickly.

Overall, the cardiac pacemaker is a valuable tool for managing heart rhythm disorders and improving the quality of life for patients who have abnormal heart rhythms. It is an effective and safe treatment option that has been used successfully for decades.

Cardiac Pacemaker Market Segmentations

Market Breakup by Product Type

  • MRI Compatible Pacemaker
  • Conventional Pacemaker
  • Implantable Pacemakers
  • External Pacemakers

Market Breakup by Technology

  • Single Chamber Pacemaker
  • Dual Chamber Pacemaker
  • Biventricular/CRT Pacemaker

Market Breakup by Applications

  • Arrhythmia
  • Atrial Fibrillation
  • Bradycardia
  • Tachycardia
  • Others

Market Breakup by End User

  • Cardiac Centres
  • Ambulatory surgical Centres
  • Hospitals
  • Clinics
  • Others

Cardiac Pacemaker Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Cardiac Pacemaker Market Scenario

The cardiac pacemaker market is a rapidly growing segment of the medical device industry. The increasing prevalence of heart rhythm disorders, such as bradycardia and heart block, has contributed to the growth of the market. Additionally, the rise in the geriatric population and the adoption of unhealthy lifestyles have further increased the demand for pacemakers.

Advancements in pacemaker technology have led to the development of smaller, more reliable, and more advanced devices that offer longer battery life and more sophisticated programming options. The integration of wireless connectivity and remote monitoring capabilities in pacemakers has also improved patient outcomes by enabling physicians to monitor patients' heart rhythm remotely and adjust the device settings accordingly.

The market is witnessing partnerships and collaborations among companies to expand their product offerings and reach a wider customer base. The cardiac pacemaker market is highly competitive, with several players offering a range of products and services. The market is also seeing an increasing trend of customization, with pacemakers being designed to meet the unique needs of individual patients.

Moreover, the COVID-19 pandemic has accelerated the adoption of telehealth services, including remote cardiac monitoring and pacemaker monitoring. This has led to an increase in the use of remote monitoring devices and telehealth services, which enable remote monitoring and consultation with healthcare professionals.

Overall, the cardiac pacemaker market is expected to continue growing in the coming years, driven by technological advancements, rising demand for remote monitoring, and increasing partnerships among players in the market. The market is poised for growth as healthcare providers and patients continue to recognize the benefits of pacemaker therapy for managing heart rhythm disorders.

Key Players in the Global Cardiac Pacemaker Market

The report gives an in-depth analysis of the key players involved in the cardiac pacemaker market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Zoll Medical Corporation
  • MicroPort Scientific Corporation
  • OSCOR Inc
  • Osypka Medical GmbH
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • LivaNova
  • Pacetronix
  • Osypka Medical
  • Lepu Medical Co ltd

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cardiac Pacemaker Market Overview
3.1 Global Cardiac Pacemaker Market Historical Value (2016-2022)
3.2 Global Cardiac Pacemaker Market Forecast Value (2023-2031)
4 Global Cardiac Pacemaker Market Landscape
4.1 Global Cardiac Pacemaker Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiac Pacemaker Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
4.2.4 Analysis by End User
5 Global Cardiac Pacemaker Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cardiac Pacemaker Market Segmentation
6.1 Global Cardiac Pacemaker Market by Product Type
6.1.1 Market Overview
6.1.2 MRI Compatible Pacemaker
6.1.3 Conventional Pacemaker
6.1.4 Implantable Pacemakers
6.1.5 External Pacemakers
6.2 Global Cardiac Pacemaker Market by Technology
6.2.1 Market Overview
6.2.2 Single Chamber Pacemaker
6.2.3 Dual Chamber Pacemaker
6.2.4 Biventricular/CRT Pacemaker
6.3 Global Cardiac Pacemaker Market by Applications
6.3.1 Market Overview
6.3.2 Arrhythmia
6.3.3 Atrial Fibrillation
6.3.4 Bradycardia
6.3.5 Tachycardia
6.3.6 Others
6.4 Global Cardiac Pacemaker Market by End User
6.4.1 Market Overview
6.4.2 Cardiac Centres
6.4.3 Ambulatory surgical Centres
6.4.4 Hospitals
6.4.5 Clinics
6.4.6 Others
6.5 Global Cardiac Pacemaker Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Cardiac Pacemaker Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cardiac Pacemaker Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cardiac Pacemaker Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Cardiac Pacemaker Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cardiac Pacemaker Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Zoll Medical Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 MicroPort Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 OSCOR Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Osypka Medical GmbH
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Medtronic
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Abbott
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Boston Scientific Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 LivaNova
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Pacetronix
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 MEDICO
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Osypka Medical
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Lepu Medical Co ltd.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Cardiac Pacemaker Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Zoll Medical Corporation
  • Microport Scientific Corporation
  • Oscor Inc.
  • Osypka Medical GmbH
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Biotronik
  • Livanova
  • Pacetronix
  • Medico
  • Osypka Medical
  • Lepu Medical Co Ltd.



Table Information